JOHNSON KENNETH ERLAND 4
4 · Xeris Biopharma Holdings, Inc. · Filed Jan 7, 2025
Insider Transaction Report
Form 4
JOHNSON KENNETH ERLAND
See Remarks
Transactions
- Tax Payment
Common Stock
2025-01-03$3.61/sh−12,401$44,768→ 361,764 total
Footnotes (2)
- [F1]Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of Restricted Stock Units vested as of January 3, 2025.
- [F2]Includes 1,129 shares acquired on December 31, 2024 under the Xeris Pharmaceuticals, Inc. 2018 Employee Stock Purchase Plan, as amended.